Apollo Management Holdings, L.P. Aurinia Pharmaceuticals Inc. Transaction History
Apollo Management Holdings, L.P.
- $4.89 Billion
- Q2 2025
Shares
2 transactions
Others Institutions Holding AUPH
# of Institutions
261Shares Held
64.7MCall Options Held
977KPut Options Held
616K-
Tang Capital Management LLC San Diego, CA10MShares$153 Million5.09% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$141 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.4 Million2.79% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.4 Million0.03% of portfolio
-
State Street Corp Boston, MA2.8MShares$42.5 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.16B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...